$2.42
-0.09[-3.59%]
At close: Apr 23
$2.42
0[0.00%]
After Hours: 7:56PM EDT
CASI Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of CASI Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/15/2024 | AM | CASI | Q1 | -$0.45 | -$0.01 | — | — | $8.35M | $13.80M | — | — | Get Alert |
03/28/2024 | AM | CASI | Q4 | -$1.44 | -$0.24 | -$0.45 | -87.50% | $15.26M | $9.41M | $6.87M | -26.95% | Get Alert |
11/14/2023 | AM | CASI | Q3 | -$0.38 | -$0.56 | -$0.35 | 37.50% | $10.21M | $10.40M | $8.84M | -15.02% | Get Alert |
08/11/2023 | AM | CASI | Q2 | -$0.56 | -$0.50 | -$0.77 | -54.00% | $8.57M | $10.09M | $9.82M | -2.68% | Get Alert |
05/17/2023 | AM | CASI | Q1 | -$0.62 | -$0.64 | -$0.45 | 29.69% | $9.06M | $9.10M | $8.35M | -8.27% | Get Alert |
04/26/2023 | AM | CASI | Q4 | -$0.40 | -$0.37 | -$1.44 | -289.19% | $9.16M | $10.79M | $15.26M | 41.42% | Get Alert |
11/14/2022 | AM | CASI | Q3 | -$0.73 | -$0.46 | -$0.38 | 17.39% | $8.11M | $9.90M | $10.21M | 3.16% | Get Alert |
08/12/2022 | AM | CASI | Q2 | -$0.40 | -$0.64 | -$0.56 | 12.50% | $7.16M | $7.87M | $8.57M | 8.93% | Get Alert |
05/12/2022 | AM | CASI | Q1 | -$1.10 | -$0.90 | -$0.60 | 33.33% | $5.74M | $9.23M | $9.06M | -1.82% | Get Alert |
03/28/2022 | AM | CASI | Q4 | -$1.20 | -$0.60 | -$0.40 | 33.33% | $4.82M | $9.07M | $9.16M | 0.97% | Get Alert |
11/12/2021 | AM | CASI | Q3 | -$1.40 | -$0.50 | -$0.70 | -40.00% | $4.24M | $7.54M | $8.11M | 7.59% | Get Alert |
08/12/2021 | AM | CASI | Q2 | -$0.90 | -$0.70 | -$0.50 | 28.57% | $2.67M | $6.02M | $7.16M | 18.97% | Get Alert |
05/13/2021 | AM | CASI | Q1 | -$0.90 | -$0.60 | -$1.10 | -83.33% | $3.41M | $5.05M | $5.74M | 13.58% | Get Alert |
03/30/2021 | AM | CASI | Q4 | -$1.30 | -$0.70 | -$1.20 | -71.43% | $1.34M | $4.45M | $4.82M | 8.36% | Get Alert |
11/09/2020 | AM | CASI | Q3 | -$1.00 | -$0.50 | -$1.40 | -180.00% | $2.79M | $3.44M | $4.24M | 23.31% | Get Alert |
08/10/2020 | AM | CASI | Q2 | -$1.60 | -$0.80 | -$0.90 | -12.50% | $0.00 | $3.75M | $2.67M | -28.77% | Get Alert |
05/11/2020 | AM | CASI | Q1 | -$0.90 | -$1.10 | -$0.90 | 18.18% | $0.00 | $790.00K | $3.41M | 331.14% | Get Alert |
03/16/2020 | AM | CASI | Q4 | -$1.00 | — | -$1.30 | — | $0.00 | — | $1.34M | — | Get Alert |
11/12/2019 | AM | CASI | Q3 | -$1.00 | — | -$1.00 | — | $0.00 | — | $2.79M | — | Get Alert |
CASI Pharmaceuticals (CASI) is scheduled to report earnings on May 15, 2024. The last reported earnings were for reported on March 28, 2024 for Q4.
The Actual EPS was $-0.45, which missed the estimate of $-0.24.
The Actual Revenue was $6.9M, which missed the estimate of $9.4M.
Browse earnings estimates, EPS, and revenue on all stocks.